US FDA revokes authorization for four COVID treatments

(Reuters) – The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for five COVID-19 treatments, including those from Eli Lilly (NYSE:LLY) and Regeneron (NASDAQ:REGN).

Source

Leave a Reply

Your email address will not be published. Required fields are marked *